CellReady
Sponsors
Centre Hospitalier Universitaire De Toulouse
Conditions
Systemic sclErodermaSystemic sclerosis
Phase 2
SUBCUTANEOUS INJECTIONS OF CULTURED ADIPOSE-DERIVED STROMA/ STEM CELLS TO HEAL REFRACTORY ISCHEMIC DIGITAL ULCERS IN PATIENTS WITH SCLERODERMA:
A PHASE II STUDY
RecruitingCTIS2023-508432-53-00
Start: 2020-09-22Target: 32Updated: 2026-01-19
Efficacy and safety of allogenic cultured Adipose-derived mesenchymal stromal cell injections on MoUth fibrosis and handicap in patients with Systemic sclEroderma
Not yet recruitingCTIS2024-518516-39-00
Target: 50Updated: 2025-08-01